Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Alternext  >  Eurobio Scientific    ALERS   FR0013240934

EUROBIO SCIENTIFIC (ALERS)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
09/18/2018 09/19/2018 09/20/2018 09/21/2018 09/24/2018 Date
4.46(c) 4.47(c) 4.575(c) 4.4(c) 4.345 Last
138 342 2 809 1 932 18 047 8 151 Volume
+0.90% +0.22% +2.35% -3.83% -1.25% Change
More quotes
Financials (EUR)
Sales 2018 50,5 M
EBIT 2018 -0,15 M
Net income 2018 -
Debt 2018 7,90 M
Yield 2018 -
Sales 2019 54,4 M
EBIT 2019 2,15 M
Net income 2019 -
Debt 2019 6,00 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 1,01x
EV / Sales2019 0,91x
Capitalization 43,3 M
More Financials
Company
Eurobio-Scientific SA engages in the research and commercialization of diagnostic products.Its portfolio consists of proprietary diagnostic products in the following areas: transplantation, infectious diseases and cancer diagnosis.Diaxonhit was founded on October 15, 1997 and is headquartered in... 
More about the company
Latest news on EUROBIO SCIENTIFIC
07/23EUROBIO SCIENTIFIC : 2018 mid-year activity report
GL
07/23EUROBIO SCIENTIFIC : 2nd quarter earnings
CO
07/16EUROBIO SCIENTIFIC : acquires Dendritics, a company specializing in antibody dev..
GL
More news
Sector news : Biotechnology & Medical Research - NEC
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug in First European Setback -..
DJ
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug for Some Patients Despite D..
DJ
09/19GILEAD SCIENCES : UK rejects adult Novartis CAR-T therapy, after 'yes' in kids
RE
09/18REGENERON PHARMACEUTICALS : Sanofi pledges to keep up its restructuring efforts
RE
09/14Allogene, Which Announced Pfizer Agreement in April, Discloses IPO Plans
DJ
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
07/24$ALEHT EUROBIO SCIENTIFIC. Turnover H1 2018. In accordance with expectations.. 
07/17MidCap Partners - EUROBIO SCIENTIFIC. Strengthening Life Sciences: EUROBIO SC.. 
06/26$ALEHT EUROBIO SCIENTIFIC. Initiation of coverage: A leader in in vitro diag.. 
More tweets
Qtime:8
Chart EUROBIO SCIENTIFIC
Duration : Period :
Eurobio Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EUROBIO SCIENTIFIC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 7,43 €
Spread / Average Target 69%
EPS Revisions
Managers
NameTitle
Jean-Michel Carle Chairman-Management Board
Jean-Pierre Hermet Chairman-Supervisory Board
Hervé Duchesne de Lamotte Chief Financial Officer
Michel Picot Member-Supervisory Board
Patrick de Roquemaurel Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
EUROBIO SCIENTIFIC0.00%53
CELLTRION, INC.--.--%33 388
IQVIA HOLDINGS INC30.32%25 763
LONZA GROUP18.80%24 291
INCYTE CORPORATION-29.69%14 156
SEATTLE GENETICS, INC.45.35%12 348